The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with ...

Dr. Deephak Swaminath and his team at Medical Center Hospital were the first in West Texas to use the Pulse Select PFA (pulsed field ablation) system. Pulse Select PFA is an emerging and newer, ...

KANSAS CITY, Mo. — St. Luke’s Mid America Heart Institute helped a groundbreaking clinical trial for patients with irregular heart rhythms take off this year. Atrial fibrillation, or Afib, is the most ...

YORK, Pa. — A clinical trial studying innovative technology to correct atrial fibrillation shows the new treatment is just as effective and safe as prior methods. FOX43 talked to the first person in ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Atrial fibrillation (AFib) can lead to strokes and heart failure, ...

A new treatment for atrial fibrillation is available to cardiac patients at OhioHealth Mansfield Hospital. Pulsed field ablation (PFA), which uses shorts bursts of high energy to neutralize abnormal ...

Ascension St. Vincent’s Riverside is pioneering pulsed field ablation, a non-thermal treatment for atrial fibrillation (AFib). This new technique offers a safer and faster alternative to traditional ...

This content is sponsored by MedStar Washington Hospital Center. Atrial fibrillation, or AFib, is the most common type of irregular heartbeat with at least 2.7 million Americans affected, according to ...

Evanston, Ill.-based Northwestern University and Baltimore-based Johns Hopkins University were awarded the first-ever national grant to study wearables in atrial fibrillation treatment, Northwestern ...